Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL989034 | 0.91 | HPGD (0.46) | HPGDPOLBALDH1A1L3MBTL1ATM | |
| SCHEMBL20512976 | 0.85 | SMN1; SMN2 (0.42) | HPGDPOLBALDH1A1L3MBTL1ATM | |
| SCHEMBL2771670 | 0.80 | NR1H4 (0.40) | HPGDPOLBALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL988213 | 0.78 | POLB (0.40) | HPGDPOLBALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL37050 | 0.78 | LMNA (0.40) | HPGDPOLBSMN1; SMN2CES2CES1 | |
| SCHEMBL8514991 | 0.77 | HPGD (0.46) | HPGDPOLBALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL711235 | 0.77 | SMN1; SMN2 (0.46) | HPGDPOLBALDH1A1L3MBTL1ATM | |
| SCHEMBL6383471 | 0.74 | KMT2A (0.38) | HPGDSMN1; SMN2 | |
| SCHEMBL2771466 | 0.74 | KMT2A (0.44) | HPGDPOLBALDH1A1SMN1; SMN2CES2 | |
| SCHEMBL7182450 | 0.73 | FABP3 (0.39) | HPGDPOLBALDH1A1SMN1; SMN2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2025-01-30 | — | — | US | disclosed |
| EP-3646847-B1 | TWO-PASTE TYPE DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2025-01-29 | — | — | EP | disclosed |
| WO-2024253204-A1 | CURABLE DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2024-12-12 | — | — | WO | disclosed |
| EP-4445891-A1 | DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118338879-A | Curable composition for dental use | 可乐丽则武齿科株式会社 | 2024-07-12 | — | — | CN | disclosed |
| WO-2023106419-A1 | DENTAL CURABLE COMPOSITION | クラレノリタケデンタル株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-110785159-B | Dual paste type curable dental composition | 可乐丽则武齿科株式会社 | 2023-06-09 | — | — | CN | disclosed |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | KURARAY NORITAKE DENTAL INC. (JP) | 2023-02-16 | — | — | US | disclosed |
| CN-112940432-B | Polymerizable monomer for dental material, composition, adhesive dental material, and kit | 三井化学株式会社 | 2022-12-30 | — | — | CN | disclosed |
| EP-2409997-A1 | REDOX-CURING TYPE COMPOSITION | Kuraray Medical Inc. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120016094-A1 | REDOX-CURING TYPE COMPOSITION | KURARAY MEDICAL INC. (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20100087613-A1 | DIVIDED REDOX-CURING TYPE COMPOSITION | KURARAY MEDICAL INC. (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2110392-A1 | MULTI-PART REDOX-CURING-TYPE COMPOSITION | Kuraray Medical Inc. (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-20090068123-A1 | FLUORINE ION-RELEASABLE COMPOSITION FOR DENTAL PURPOSES | KURARAY MEDICAL INC (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-1864645-A1 | FLUORINE ION-RELEASABLE COMPOSITION FOR DENTAL PURPOSES | Kuraray Medical Inc. (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-1236459-B1 | PHOTO-CURABLE REPARATIVE MATERIAL FOR DENTAL USE | TOKUYAMA CORP (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-6849670-B2 | Photo-curable reparative material for dental use | TOKUYAMA CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
| US-20030162863-A1 | Photo-curable reparative material for dental use | TOKUYAMA CORPORATION (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1236459-A1 | PHOTO-CURABLE REPARATIVE MATERIAL FOR DENTAL USE | TOKUYAMA CORPORATION (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | H1-0, COL1A1, CHAF1B | HPGD 2520/4885POLB 1654/4885ALDH1A1 1530/4885 |
| US-20090068123-A1 | FLUORINE ION-RELEASABLE COMPOSITION FOR DENTAL PURPOSES | ITGA5, ITGAL, PHOSPHO1 | HPGD 4465/4885POLB 3824/4885ALDH1A1 3682/4885 |
| US-20030162863-A1 | Photo-curable reparative material for dental use | MBTD1, AP3M1, MYO1G | HPGD 3210/4885POLB 737/4885ALDH1A1 1806/4885 |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | PFN1, XRN2, FLNA | HPGD 3548/4885POLB 596/4885ALDH1A1 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.